Page last updated: 2024-09-03

ginsenoside rh2 and ciprofloxacin

ginsenoside rh2 has been researched along with ciprofloxacin in 2 studies

Compound Research Comparison

Studies
(ginsenoside rh2)
Trials
(ginsenoside rh2)
Recent Studies (post-2010)
(ginsenoside rh2)
Studies
(ciprofloxacin)
Trials
(ciprofloxacin)
Recent Studies (post-2010) (ciprofloxacin)
295120016,0601,3316,092

Protein Interaction Comparison

ProteinTaxonomyginsenoside rh2 (IC50)ciprofloxacin (IC50)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)0.41
DNA gyrase subunit BBacillus subtilis subsp. subtilis str. 1686.3
DNA gyrase subunit ABacillus subtilis subsp. subtilis str. 1686.3
Cytochrome P450 3A4Homo sapiens (human)0.31
DNA gyrase subunit BStaphylococcus aureus4.32
DNA gyrase subunit AEscherichia coli K-120.6845
DNA gyrase subunit BEscherichia coli K-120.5632
DNA topoisomerase 4 subunit BStaphylococcus aureus6.485
DNA topoisomerase 4 subunit AStaphylococcus aureus4.8011
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)0.41
DNA gyrase subunit AStaphylococcus aureus4.32
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)0.41
DNA topoisomerase 4 subunit ABacillus subtilis subsp. subtilis str. 1681.7
DNA topoisomerase 4 subunit BBacillus subtilis subsp. subtilis str. 1681.7
GABA theta subunitRattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)0.41

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, Q; He, J; Liu, J; Lu, M; Sun, X; Sun, Y; Wang, G; Wang, Y; Zhang, J; Zhang, X; Zhou, F1
Long, J; Lu, C; Pan, X; Sun, M; Wu, C; Zhu, C1

Other Studies

2 other study(ies) available for ginsenoside rh2 and ciprofloxacin

ArticleYear
Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
    European journal of pharmacology, 2014, Oct-05, Volume: 740

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Synergism; Ginsenosides; Male; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Peritonitis; Protein Conformation; Pyronine; RNA, Messenger; Staphylococcal Infections; Staphylococcus aureus

2014
PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat
    Drug delivery, 2020, Volume: 27, Issue:1

    Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Delivery Systems; Drug Liberation; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Ginsenosides; HaCaT Cells; Humans; Hydrogels; Methicillin-Resistant Staphylococcus aureus; Mice; Microspheres; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcal Skin Infections; Staphylococcus aureus

2020